Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Perfusion for Refractory Cancer Visceral Pain
NCT00181012Phase 3Unknown
- Sponsor
- Gustave Roussy
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine in cancer pain, sponsored by Gustave Roussy. Primary endpoint: Lidocaine efficacy at 6 days. Status: unknown.
02
Drugs
lidocaine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00181012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181012.